Joseph Gordon, FACHE is the new CEO of Tampa, Florida-based Florida Orthopaedic Institute (FOI).
Joseph R. Gordon New CEO of Florida Orthopaedic Institute
1 min read Premium comments
#josephgordon
He brings over 30 years of senior-level operations and business development experience in healthcare. Prior to this position, Gordon served as SVP & Chief Strategy Officer for General Medicine in Novi, Michigan. Before General Medicine, he served as Strategy Director for the HM Home and Community Services division of Highmark Health.
Gordon earned a bachelor’s degree from Michigan State University and a master’s degree in Hospital and Health Administration from Xavier University in Cincinnati, Ohio.
His past experience includes a wide variety of healthcare companies including Community Health Systems, Health Connextions, Fresenius Medical Care AG & Co., FVC, Select Medical Corporation, LTACH Hospital Group, Select Specialty Hospitals, Brooks Rehabilitation Solutions, GNA Respiratory, Grancare, Timken Mercy Medical Center, Kindred, Outer Drive, and Seaway Hospitals.
“Joe has the depth of knowledge needed for strategic growth going forward, and has the operational skill set the FOI Board requires,” says Roy Sanders, M.D., FOI president and chief medical officer. “He is a strong motivator with creative problem-solving abilities. Joe is results-oriented with extensive start-up experience and brings significant multi-site, multi-state operational knowledge to our Institute, while maintaining an exceptional reputation in the profession with proven, measurable results. We all look forward to the expertise and enthusiasm Joe brings.”
Joe Gordon told OTW, “My initial focus is truly one of listening and learning. It is critical to first understand the history of FOI by meeting with all of our physicians and leadership team. Secondly, it will be important for me to engage many of our front-line staff that have contributed much to FOI’s success to share my overall vision and to hear from them as well. Fostering a culture of accountability, results orientation, professionalism, respect and clinical excellence starts with the CEO. Also, during this early period I will be assessing our organization for opportunities and areas of risk, improvement, growth and efficiencies to ensure an exceptional patient experience.”
“In the short term I see my priorities focused on the following areas: growth, strategic alliances, team building, infrastructure, systems and support for planned growth.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.